Evidence map›Paper›PMID 39136805›Full record

ArticleJournal of materials science. Materials in medicine2024

Improvement photothermal property of MoS

Behdad Shariati, Mohammad Taghi Goodarzi, Alireza Jalali, Nasrin Salehi, Majid Mozaffari

Abstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Behdad ShariatiDepartment of Biochemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran.
Mohammad Taghi GoodarziDepartment of Biochemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran. mtgoodarzi@yahoo.com.ORCID http://orcid.org/0000-0002-5546-5812
Alireza JalaliDepartment of Chemistry, Herbal Medicines Raw Materials Research Center, Shahrood Branch, Islamic Azad University, Shahrood, Iran.
Nasrin SalehiDepartment of Basic Sciences, Shahrood Branch, Islamic Azad University, Shahrood, Iran.
Majid MozaffariDepartment of Chemistry, Herbal Medicines Raw Materials Research Center, Shahrood Branch, Islamic Azad University, Shahrood, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of the present study was to develop a novel molybdenum disulfide/iron oxide/gold nanorods (MoS

Indexed as

Cell SurvivalDisulfidesDoxorubicinGoldMolybdenumNanocompositesApoptosisFerric CompoundsHeLa CellsHumansNanotubesNeoplasmsPhototherapyPhotothermal TherapySpectroscopy, Fourier Transform InfraredDisulfidesDoxorubicinFerric Compoundsferric oxideGoldMolybdenummolybdenum disulfideDOXDrug deliveryGNRMFG nanocompositePhotothermal therapy

Identifiers

PMID39136805
PMCPMC11322282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.